Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-27

Clinical Trial Update: Evaluation of Transcranial Photobiomodulation in Autism Spectrum Disorder [NA]

View source ↗

Summary

The clinical trial evaluating transcranial photobiomodulation for autism spectrum disorder has completed and results were posted on 2026-01-27.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Autism Spectrum Disorder | NA | Status: COMPLETED | Results posted: 2026-01-27